Evaluation of cortical bone mass, thickness and density by z-scores in osteopenic conditions and in relation to menopause and estrogen treatment
- PMID: 7146927
- DOI: 10.1007/BF02219620
Evaluation of cortical bone mass, thickness and density by z-scores in osteopenic conditions and in relation to menopause and estrogen treatment
Abstract
Z-scores express differences from normals in standard deviation units, and are particularly useful for comparison of changes where normal values are age- and sex-dependent. We determined z-scores for bone mineral mass, cortical thickness, and bone mineral density in the radius in various conditions and diseases in both sexes. In the males, z-scores were calculated for age, but in the females z-scores for menopausal status (years postmenopausal exclusive of years on estrogen treatment) were found to be more appropriate. With few exceptions, changes in a disease were of a similar order in both sexes. For bone mineral mass few mean z-scores were significantly increased, but diseases with significantly decreased mean z-scores were numerous. The usefulness of z-scores in diagnosis and study of metabolic bone disease is discussed.
Similar articles
-
Menopausal bone loss and estrogen replacement.Isr J Med Sci. 1976 Jul;12(7):601-6. Isr J Med Sci. 1976. PMID: 972014
-
Preventive effect of estrogen on postmenopausal bone loss.Arch Intern Med. 1975 Nov;135(11):1436-40. Arch Intern Med. 1975. PMID: 1190928
-
Quantitative ultrasound and bone mineral density are equally strongly associated with risk factors for osteoporosis.J Bone Miner Res. 2001 Feb;16(2):406-16. doi: 10.1359/jbmr.2001.16.2.406. J Bone Miner Res. 2001. PMID: 11204441
-
Identifying the osteopenic patient and preventing worsening of the disease.Curr Womens Health Rep. 2003 Jun;3(3):199-206. Curr Womens Health Rep. 2003. PMID: 12734030 Review.
-
Application of the 1994 WHO classification to populations other than postmenopausal Caucasian women: the 2005 ISCD Official Positions.J Clin Densitom. 2006 Jan-Mar;9(1):22-30. doi: 10.1016/j.jocd.2006.05.004. Epub 2006 May 12. J Clin Densitom. 2006. PMID: 16731428
Cited by
-
Biochemical short-term changes produced by hormonal replacement therapy.J Endocrinol Invest. 1991 Dec;14(11):927-34. doi: 10.1007/BF03347118. J Endocrinol Invest. 1991. PMID: 1806610 Clinical Trial.
-
Familial hypophosphatemic rickets: bone mass measurements in children following therapy with calcitriol and supplemental phosphate.Calcif Tissue Int. 1989 Feb;44(2):86-92. doi: 10.1007/BF02556466. Calcif Tissue Int. 1989. PMID: 2492895
References
MeSH terms
Substances
LinkOut - more resources
Medical